Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018060999) METHODS OF RISK ASSESSMENT AND DISEASE CLASSIFICATION
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/060999 International Application No.: PCT/IL2017/051089
Publication Date: 05.04.2018 International Filing Date: 27.09.2017
IPC:
G01N 33/68 (2006.01)
G PHYSICS
01
MEASURING; TESTING
N
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33
Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48
Biological material, e.g. blood, urine; Haemocytometers
50
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
68
involving proteins, peptides or amino acids
Applicants:
MEMED DIAGNOSTICS LTD. [IL/IL]; 5 Nahum Heth Street Park High-Tech North 3508504 Tirat HaCarmel, IL
Inventors:
OVED, Kfir; IL
EDEN, Eran; IL
COHEN-DOTAN, Assaf; IL
NAVON, Roy; IL
MASTBOIM, Niv Steven; IL
BOICO, Olga; IL
PAZ, Meital; IL
Agent:
EHRLICH, Gal; G. E. Ehrlich (1995) LTD. 11 Menachem Begin Road 5268104 Ramat Gan, IL
WATERMAN, Hadassa; IL
MELNICK, Geoffrey, L.; IL
Priority Data:
62/401,29429.09.2016US
Title (EN) METHODS OF RISK ASSESSMENT AND DISEASE CLASSIFICATION
(FR) PROCÉDÉS D'ÉVALUATION DE RISQUE ET DE CLASSIFICATION DE MALADIE
Abstract:
(EN) A method of measuring risk assessment in a patient is disclosed. The method comprises: (a) measuring the TRAIL protein level in a blood sample of the patient; (b) measuring the level of at least one disease-associated parameter in the patient; and (c) providing a risk assessment based on the combination of said TRAIL protein level and said disease-associated parameter level.
(FR) L'invention concerne un procédé de mesure de l'évaluation de risque chez un patient. Le procédé comprend : (a) la mesure du niveau de protéine TRAIL dans un échantillon de sang du patient ; (b) la mesure du niveau d'au moins un paramètre associé à une maladie chez le patient ; et (c) la fourniture d’une évaluation de risque sur la base de la combinaison dudit niveau de protéine TRAIL et dudit niveau de paramètre associé à une maladie.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)